5 Essential Elements For ABBV-744 drug development progress and timeline
In Segment A, contributors will get diverse doses and schedules of oral ABBV-744 tablet to discover Risk-free dosing regimen. Further participants will be enrolled within the determined monotherapy dosign regimen. In Phase B, contributors will get oral ruxolitinib and ABBV-744 will likely be provided as "add-on" therapy. In Section C, participants